Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-11 Sale | 2026-02-12 8:47 pm | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 7,455 | $23.39 | $174,372 | 74,266 (Direct) | View |
| 2026-02-11 Sale | 2026-02-12 8:46 pm | Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Operating Officer | 1,236 | $23.39 | $28,910 | 17,795 (Direct) | View |
| 2026-02-11 Sale | 2026-02-12 8:44 pm | Lyell Immunopharma Inc. | LYEL | Lee Gary K. Chief Scientific Officer | 1,671 | $23.39 | $39,085 | 16,938 (Direct) | View |
| 2026-02-10 Sale | 2026-02-11 9:05 pm | Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Operating Officer | 109 | $23.12 | $2,520 | 84,031 (Direct) | View |
| 2026-02-10 Sale | 2026-02-11 9:04 pm | Lyell Immunopharma Inc. | LYEL | Lee Gary K. Chief Scientific Officer | 147 | $23.12 | $3,399 | 68,609 (Direct) | View |
| 2026-02-10 Sale | 2026-02-11 9:03 pm | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 438 | $23.12 | $10,127 | 236,721 (Direct) | View |
| 2026-02-10 Sale | 2026-02-11 9:00 pm | Lyell Immunopharma Inc. | LYEL | Bulis Veronica Sanchez VP, Corporate Controller | 254 | $23.12 | $5,872 | 15,637 (Direct) | View |
| 2025-12-24 Sale | 2026-01-06 4:02 pm | Lyell Immunopharma Inc. | LYEL | Bulis Veronica Sanchez VP, Corporate Controller | 2,072 | $35.8 | $74,181 | 7,141 (Direct) | View |
| 2025-11-10 Sale | 2025-11-12 8:36 pm | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 412 | $16.11 | $6,637 | 67,159 (Direct) | View |
| 2025-11-10 Sale | 2025-11-12 8:34 pm | Lyell Immunopharma Inc. | LYEL | Bulis Veronica Sanchez VP, Corporate Controller | 239 | $16.1 | $3,848 | 9,213 (Direct) | View |
| 2025-11-10 Sale | 2025-11-12 8:33 pm | Lyell Immunopharma Inc. | LYEL | Lee Gary K. Chief Scientific Officer | 138 | $16.16 | $2,230 | 15,366 (Direct) | View |
| 2025-11-10 Sale | 2025-11-12 8:31 pm | Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Operating Officer | 95 | $16.12 | $1,531 | 15,750 (Direct) | View |
| 2025-08-21 Sale | 2025-08-22 4:07 pm | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 7,257 | $10.54 | $76,518 | 67,571 (Direct) | View |
| 2025-08-21 Sale | 2025-08-22 4:06 pm | Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Operating Officer | 1,004 | $10.54 | $10,586 | 15,845 (Direct) | View |
| 2025-08-21 Sale | 2025-08-22 4:03 pm | Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer | 1,453 | $10.54 | $15,320 | 25,306 (Indirect Direct) | View |
| 2025-08-21 Sale | 2025-08-22 4:02 pm | Lyell Immunopharma Inc. | LYEL | Lee Gary K. Chief Scientific Officer | 1,453 | $10.54 | $15,320 | 15,504 (Direct) | View |
| 2025-08-11 Sale | 2025-08-13 9:10 pm | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 797 | $10.43 | $8,313 | 34,828 (Direct) | View |
| 2025-08-11 Sale | 2025-08-13 9:09 pm | Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Operating Officer | 185 | $10.43 | $1,930 | 8,849 (Direct) | View |
| 2025-08-11 Sale | 2025-08-13 9:08 pm | Lyell Immunopharma Inc. | LYEL | Lee Gary K. Chief Scientific Officer | 267 | $10.43 | $2,785 | 8,957 (Direct) | View |
| 2025-08-11 Sale | 2025-08-13 9:06 pm | Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer | 267 | $10.43 | $2,785 | 18,759 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-10 Option Award | 2026-02-11 9:05 pm | N/A 2036-02-09 | Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Operating Officer | 69,000 | $0 | 84,031 (Direct) | View |
| 2026-02-10 Option Award | 2026-02-11 9:04 pm | N/A 2036-02-09 | Lyell Immunopharma Inc. | LYEL | Lee Gary K. Chief Scientific Officer | 54,000 | $0 | 68,609 (Direct) | View |
| 2026-02-10 Option Award | 2026-02-11 9:03 pm | N/A 2036-02-09 | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 175,000 | $0 | 236,721 (Direct) | View |
| 2026-02-10 Option Award | 2026-02-11 9:01 pm | N/A 2036-02-09 | Lyell Immunopharma Inc. | LYEL | Meltz Mark A General Counsel | 50,000 | $0 | 50,000 (Direct) | View |
| 2026-02-10 Option Award | 2026-02-11 9:00 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | Bulis Veronica Sanchez VP, Corporate Controller | 8,750 | $0 | 15,637 (Direct) | View |
| 2026-02-10 Option Award | 2026-02-11 8:58 pm | N/A 2036-02-09 | Lyell Immunopharma Inc. | LYEL | Shook David Chief Medical Officer | 50,000 | $0 | 71,900 (Direct) | View |
Ownership | 2025-11-10 9:07 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | Bulis Veronica Sanchez VP, Corporate Controller | 0 | $0 | 14,750 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-29 5:42 pm | N/A 2035-10-26 | Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Operating Officer | 75,000 | $0 | 90,845 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-29 5:41 pm | N/A 2035-10-26 | Lyell Immunopharma Inc. | LYEL | Lee Gary K. Chief Scientific Officer | 68,000 | $0 | 83,504 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-29 5:40 pm | N/A 2035-10-26 | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 175,000 | $0 | 242,571 (Direct) | View |
| 2025-08-20 Option Award | 2025-08-22 4:07 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO | 40,000 | $0 | 67,571 (Direct) | View |
| 2025-08-20 Option Award | 2025-08-22 4:06 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Operating Officer | 8,000 | $0 | 15,845 (Direct) | View |
| 2025-08-20 Option Award | 2025-08-22 4:03 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer | 8,000 | $0 | 25,306 (Direct) | View |
| 2025-08-20 Option Award | 2025-08-22 4:02 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | Lee Gary K. Chief Scientific Officer | 8,000 | $0 | 15,504 (Direct) | View |
Ownership | 2025-07-29 9:23 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | ARCH Venture Fund XIII L.P. ARCH Venture Partners XIII L.P. ARCH Venture Partners XIII LLC CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN BERNS PAUL L 10% Owner | 0 | $0 | 938,438 (Indirect) | View |
| 2025-06-09 Option Award | 2025-06-11 5:48 pm | N/A 2035-06-08 | Lyell Immunopharma Inc. | LYEL | Bachleda Mark Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-11 5:47 pm | N/A 2035-06-08 | Lyell Immunopharma Inc. | LYEL | Meltz Mark A General Counsel | 100,000 | $0 | 100,000 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-11 5:45 pm | N/A 2035-06-08 | Lyell Immunopharma Inc. | LYEL | Shook David Chief Medical Officer | 65,650 | $0 | 65,650 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 6:50 pm | N/A 2035-05-14 | Lyell Immunopharma Inc. | LYEL | Klausner Richard Director | 130,000 | $0 | 3,941,199 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 6:48 pm | N/A 2035-05-14 | Lyell Immunopharma Inc. | LYEL | RIEFLIN WILLIAM JL Director | 130,000 | $0 | 130,000 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 6:47 pm | N/A 2035-05-14 | Lyell Immunopharma Inc. | LYEL | FRIEDMAN CATHY Director | 130,000 | $0 | 466,370 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 6:45 pm | N/A 2035-05-14 | Lyell Immunopharma Inc. | LYEL | BRAWLEY OTIS W Director | 130,000 | $0 | 165,640 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 6:43 pm | N/A 2035-05-14 | Lyell Immunopharma Inc. | LYEL | NABEL ELIZABETH G Director | 130,000 | $0 | 130,000 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 6:41 pm | N/A 2035-05-14 | Lyell Immunopharma Inc. | LYEL | Ramachandra Sumant Director | 130,000 | $0 | 330,000 (Direct) | View |